Home LiteratureArticle Details
PMID: 3840245 Published · ppublish English Clinical Trial Comparative Study Journal Article Randomized Controlled Trial

Management of retinopathy of prematurity.

Ophthalmology ·Vol. 92 ·No. 8 ·1985-08-00 ·Pages 995-9

Tasman W

Abstract

Seventeen patients with symmetrical stage 3 retinopathy of prematurity (ROP) and plus disease as described in the International Classification of ROP had one eye randomized to cryotherapy and the other to control. Seventy-seven percent of the patients were under 1000 grams at birth and females outnumbered males by a 2 to 1 ratio. The average chronologic age at which cryotherapy was performed was three months. Twelve of seventeen treated eyes (71%) showed resolution of the ROP and 10 of 17 untreated eyes (59%) became significantly worse. However, only five patients had improvement in the treated eye and progression in the untreated eye, a number too small to provide statistical significance. Six eyes with Stage IV ROP were operated by encircling scleral buckling techniques because of total retinal detachment secondary to peripheral traction and cicatrization arising from the ridge. In five patients the unoperated eye had already developed a retrolental membrane, and in one patient bilateral detachments were present. Five of the six operated retinas were reattached.

MeSH Terms
Cryosurgery Female Humans Infant Male Retinal Vessels Retinopathy of Prematurity/pathology,surgery
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Tasman W
Article Info
Journal
Ophthalmology
Abbr.
Ophthalmology
ISSN
0161-6420
Published
1985-08-00
Pages
995-9
Language
English
Region
United States
NLM ID
7802443
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]